Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension
Acta Physiologica · 2024-11 · 240 (11)
DOI: 10.1111/apha.14226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 10.09.2024. Verfasst von Moritz I Wimmer und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität z…. Hauptthemen laut MEDLINE: Metformin, Hypertension, Gastrointestinal Microbiome, Blood Pressure. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Herz-Kreislaufforschung.
Abstract (Originalsprache)
Aims
Metformin has been attributed to cardiovascular protection even in the absence of diabetes. Recent observations suggest that metformin influences the gut microbiome. We aimed to investigate the influence of metformin on the gut microbiota and hypertensive target organ damage in hypertensive rats.
Methods
Male double transgenic rats overexpressing the human renin and angiotensinogen genes (dTGR), a model of angiotensin II‐dependent hypertension, were treated with metformin (300 mg/kg/day) or vehicle from 4 to 7 weeks of age. We assessed gut microbiome composition and function using shotgun metagenomic sequencing and measured blood pressure via radiotelemetry. Cardiac and renal organ damage and inflammation were evaluated by echocardiography, histology, and flow cytometry.
Results
Metformin treatment increased the production of short‐chain fatty acids (SCFA) acetate and propionate in feces without altering microbial composition and diversity. It significantly reduced systolic and diastolic blood pressure and improved cardiac function, as measured by end‐diastolic volume, E/A, and stroke volume despite increased cardiac hypertrophy. Metformin reduced cardiac inflammation by lowering macrophage infiltration and shifting macrophage subpopulations towards a less inflammatory phenotype. The observed improvements in blood pressure, cardiac function, and inflammation correlated with fecal SCFA levels in dTGR. In vitro, acetate and propionate altered M1‐like gene expression in macrophages, reinforcing anti‐inflammatory effects. Metformin did not affect hypertensive renal damage or microvascular structure.
Conclusion
Metformin modulated the gut microbiome, increased SCFA production, and ameliorated blood pressure and cardiac remodeling in dTGR. Our findings confirm the protective effects of metformin in the absence of diabetes, highlighting SCFA as a potential mediators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin Berlin, Max Delbruck Center for Molecular Medicine, Berlin, Germany.
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
- DZHK (German Centre for Cardiovascular Research), Berlin, Germany.
- Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
ORCID-Profile: Moritz I Wimmer, Hendrik Bartolomaeus, Harithaa Anandakumar, Chia-Yu Chen, Valentin Vecera, Sarah Kedziora, Sakshi Kamboj, Fabian Schumacher, Ariana Rauch, Olena Potapenko, Alex Yarritu, Theda U P Bartolomaeus, Mariam Samaan, Arne Thiele, Sabrina Y Geisberger, Burkhard Kleuser, Peter J Oefner, Nadine Haase, Ulrike Löber, Wolfram Gronwald, Sofia K Forslund-Startceva, Dominik N Müller, Nicola Wilck
Förderung
- Deutsche Forschungsgemeinschaft
- Deutsches Zentrum für Herz-Kreislaufforschung
Zitieren
APA
Wimmer, M. I., Bartolomaeus, H., Anandakumar, H., Chen, C. Y., Vecera, V., Kedziora, S., Kamboj, S., Schumacher, F., Pals, S., Rauch, A., Meisel, J., Potapenko, O., Yarritu, A., Bartolomaeus, T. U. P., Samaan, M., Thiele, A., Stürzbecher, L., Geisberger, S. Y., Kleuser, B., …, & Wilck, N. (2024). Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension. Acta Physiologica, 240(11). https://doi.org/10.1111/apha.14226
Vancouver
Wimmer MI, Bartolomaeus H, Anandakumar H, Chen CY, Vecera V, Kedziora S, et al. Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension. Acta Physiologica. 2024;240(11). doi:10.1111/apha.14226
BibTeX
@article{Wimmer2024,
author = {Wimmer, Moritz I and Bartolomaeus, Hendrik and Anandakumar, Harithaa and Chen, Chia-Yu and Vecera, Valentin and Kedziora, Sarah and Kamboj, Sakshi and Schumacher, Fabian and Pals, Sidney and Rauch, Ariana and Meisel, Jutta and Potapenko, Olena and Yarritu, Alex and Bartolomaeus, Theda U P and Samaan, Mariam and Thiele, Arne and Stürzbecher, Lucas and Geisberger, Sabrina Y and Kleuser, Burkhard and Oefner, Peter J and Haase, Nadine and Löber, Ulrike and Gronwald, Wolfram and Forslund-Startceva, Sofia K and Müller, Dominik N and Wilck, Nicola},
title = {Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension},
journal = {Acta Physiologica},
year = {2024},
volume = {240},
number = {11},
doi = {10.1111/apha.14226}
}
EUVIMED